Article | August 5, 2021

The Cell & Gene Talent Crunch: Attracting Top-Notch Employees In A Competitive Landscape

Source: Cytiva

By Cytiva

Scientist lab cell and gene dna GettyImages-1305079941

Talent and training programs can make a big difference in a molecule’s progress to commercialization, yet in the biopharmaceutical industry, talent is in short supply.

For emerging biopharma companies which may lack reach and resources, understanding how to develop, attract, and retain an advanced therapy, development, manufacturing, and clinical workforce is especially critical.

Michael Mehler, the senior clinical development manager for cell therapy oncology at GlaxoSmithKline, one of the largest pharmaceutical companies in the world, has observed over time how even one small batch with an error can negatively affect patients and cost a company its reputation and millions of dollars.

Mehler shares what it takes to identify and draw a trained workforce to your doorstep for both small and large pharmaceutical organizations.

VIEW THE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma